Low-density lipoprotein triglyceride predicts outcomes in patients with chronic coronary syndrome following percutaneous coronary intervention according to inflammatory status-Reference-Cited by-同舟云学术

Low-density lipoprotein triglyceride predicts outcomes in patients with chronic coronary syndrome following percutaneous coronary intervention according to inflammatory status

Published:2023-11 Issue: Volume:551 Page:117631
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Zhang Hui-Wen,Guo Yuan-Lin,Wu Na-Qiong,Zhu Cheng-Gang,Dong Qian,Sun Jing,Dou Ke-Fei,Li Jian-Jun

Publisher

Elsevier BV

Subject

Biochemistry (medical),Clinical Biochemistry,Biochemistry,General Medicine

Reference30 articles.

1. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT;Bohula;Circulation,2015

2. Residual inflammatory risk on treatment with PCSK9 inhibition and statin therapy;Pradhan;Circulation,2018

3. Inflammatory and cholesterol risk in the FOURIER trial;Bohula;Circulation,2018

4. Residual inflammatory risk in patients with low LDL cholesterol concentrations undergoing percutaneous coronary intervention;Guedeney;J. Am. Coll. Cardiol.,2019

5. Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study;Marz;Circulation,2004

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing chronic coronary syndrome: how do we achieve optimal patient outcomes?;Expert Review of Cardiovascular Therapy;2024-05-20